Hovione recently announced a partnership to advance the development of multi-purpose, plug-and-play modular equipment for flow chemistry. This collaboration aims to leverage Microinnova’s innovative modular manufacturing technology in an industrial setting, enhancing the production of active pharmaceutical ingredients.
The Microinnova equipment promises greater flexibility, scalability, and efficiency, aligning with the industry’s increasing demand for sustainable manufacturing practices. By streamlining the transition from laboratory to large-scale production, this partnership is poised to significantly reduce time to market for pharmaceutical clients, thereby enhancing their competitive edge.
Dr. Jean-Luc Herbeaux, CEO of Hovione, emphasized that this initiative underscores the company’s commitment to innovation in pharmaceutical manufacturing. Meanwhile, Dr. Dirk Kirschneck of Microinnova highlighted their shared vision to deliver cutting-edge modular technologies that foster pharmaceutical innovation. Together, they aim to validate and implement continuous manufacturing technologies that could revolutionize drug development and production processes.
Start your 7-day trial and see what the database can do →
